Form NPORT-P T. Rowe Price Growth For: Mar 31
Tweet
Share
E-mailSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma
- Best Infrared Saunas of 2026 [Expert Reviewed and Independently Verified]
- Roofing Expert Matt Waligorski of Livonia Outlines What Makes a Roofer Truly Trustworthy for HelloNation
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
